MAbSA
Monoclonal Antibodies South Australia (MAbSA) Technologies is a joint venture between the Institute of Medical and Veterinary Science (IMVS) and University of Adelaide. MAbSA fuses the services, and many years of experience, of these two world class institutions into a single monoclonal antibody facility.
MAbSA provides custom design of immunogen, antigen conjugation, hybridoma development, cell culture production, hybridoma screening, cell cloning, and cryo-storage of clones. They grow your pre-existing hybridoma cell line (or hybridomas produced by MAbSA) to produce small or large scale quantities of purified monoclonal antibody for you.
All clones, hybridomas, and antibody produced by MAbSA from antigen provided by the client for use in the hybridoma-generation process, remain the exclusive property of the client. Each project is conducted with complete confidentiality.
MAbSA technologies are located in Room 3.18 Molecular Life Sciences Building, The University of Adelaide.
For further information on services or for ordering go to www.adelaide.edu.au/mbs/mabsa
